Is AAPG or ABOS more undervalued in 2026?

CirclFi compares Ascentage Pharma Group Internat (AAPG) and Acumen Pharmaceuticals, Inc. (ABOS) using 13 institutional-grade valuation models. AAPG has a Quality of Company score of 4.7/10 while ABOS scores 4.3/10.

Which is a better buy — AAPG or ABOS?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do AAPG and ABOS valuations compare?

AAPG at $20.01 and ABOS at $2.60 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

AAPG vs ABOS Valuation Comparison 2026 — Intrinsic Value Analysis

AAPG

Biotechnology

Ascentage Pharma Group Internat

Quality

4.7

out of 10

Value Trap

—

Price

$20.01

Last close

Models

12/13

Active

ABOS

Biotechnology

Acumen Pharmaceuticals, Inc.

Quality

4.3

out of 10

Value Trap

SAFE

Price

$2.60

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	AAPG Fair Value	AAPG Upside	ABOS Fair Value	ABOS Upside
Bayesian DCF	Intrinsic	$2.81	-86.0%	$0.92	-64.7%
Earnings Power Value	Intrinsic	$0.73	-96.9%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.00	-100.0%	$1.71	-34.4%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for AAPG vs ABOS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

AAPG vs ABOS — Which Stock Is More Undervalued?

AAPG scores higher with a 4.7/10 quality rating vs ABOS's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Ascentage Pharma Group Internat (AAPG) and Acumen Pharmaceuticals, Inc. (ABOS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

AAPG currently trades at $20.01 with a QOC of 4.7/10, while ABOS trades at $2.60 with a QOC of 4.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).